NPR Coronavirus Updates

FDA Grants Emergency Authorization For A 2nd COVID-19 Antibody Treatment

By Matthew S. Schwartz

Published November 22, 2020 at 10:00 AM MST

The experimental cocktail from the biotech company Regeneron is the same drug President Trump got when he was battling the coronavirus this year. It is designed for mild to moderate cases.

Corrected: November 21, 2020 at 10:00 PM MST

An earlier version of this story misspelled George Yancopoulos' last name as Yancopoulous.

NPR Coronavirus Updates

Matthew S. Schwartz

Matthew S. Schwartz is a reporter with NPR's news desk. Before coming to NPR, Schwartz worked as a reporter for Washington, DC, member station WAMU, where he won the national Edward R. Murrow award for feature reporting in large market radio. Previously, Schwartz worked as a technology reporter covering the intricacies of Internet regulation. In a past life, Schwartz was a Washington telecom lawyer. He got his J.D. from Georgetown University Law Center, and his B.A. from the University of Michigan ("Go Blue!").

See stories by Matthew S. Schwartz